This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Antipsychotics and Metabolic Syndrome

This study has suspended participant recruitment.
(this study has not finding place)
Information provided by:
Glostrup University Hospital, Copenhagen Identifier:
First received: March 7, 2008
Last updated: July 29, 2010
Last verified: July 2010
The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.

Metabolic Syndrome

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Glostrup University Hospital, Copenhagen:

Biospecimen Retention:   None Retained
whole blood, serum/plasma

Estimated Enrollment: 60
Study Start Date: September 2008
Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
schizophrenic patients


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients with debut of schizophrenia, controls from database

Inclusion Criteria:

  • Gender male
  • Age 18-45
  • Debut drug-naive schizophrenics,
  • Caucasians
  • Consent given to take part in the project

Exclusion Criteria:

  • Compliance-problems
  • Major lung-/kidney/hart/lever disorders
  • Abuse of alcohol/drugs
  • Diabetes 1 and 2
  • Antihypertensive
  • Anticholesterol-reducing medication
  • Patients under duress
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00636753

Psychiatric Center Glostrup
Copenhagen, Nordre Ringvej 28-69, Glostrup, Denmark, 2600
Psychiatric Center Glostrup
Nordre Ringvej 28-69, Glostrup, Denmark, 2600
Sponsors and Collaborators
Glostrup University Hospital, Copenhagen
  More Information

Responsible Party:, centerchef Henrik Lublin, Psychiatric Center Glostrup Identifier: NCT00636753     History of Changes
Other Study ID Numbers: HC-2007-0070
Study First Received: March 7, 2008
Last Updated: July 29, 2010

Keywords provided by Glostrup University Hospital, Copenhagen:
Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.

Additional relevant MeSH terms:
Metabolic Syndrome X
Pathologic Processes
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Diseases
Antipsychotic Agents
Tranquilizing Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Psychotropic Drugs processed this record on August 17, 2017